AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22775481 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily
Number of subjects: 105
Study 22775481 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous combined oral E(2) 2 mg/NETA 1 mg daily
Number of subjects: 105
Study 22775481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 21915249 — intervention group
Group type: EXPERIMENTAL
Intervention: Carraguard vaginal gel
Number of subjects: 60
Study 21915249 — intervention group
Group type: COMPARATOR
Intervention: Methylcellulose placebo gel
Number of subjects: 60
Study 21915249 — intervention group
Group type: COMPARATOR
Intervention: No product
Number of subjects: 60
Study 18353393 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg 3 times a day)
Number of subjects: 40
Study 18353393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 17166821 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral taping
Number of subjects: 24
Study 17166821 — intervention group
Group type: COMPARATOR
Intervention: Medial taping
Number of subjects: 24
Study 17166821 — intervention group
Group type: COMPARATOR
Intervention: Neutral taping
Number of subjects: 24
Study 17166821 — intervention group
Group type: COMPARATOR
Intervention: No-tape
Number of subjects: 24
Study 14977479 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose immunosuppression followed by autologous hematopoietic stem cell transplantation
Number of subjects: 200
Study 14977479 — intervention group
Group type: COMPARATOR
Intervention: Mitoxantrone (best available therapy)
Number of subjects: 200
Study 11566828 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice therapy for six weeks
Number of subjects: 204
Study 11566828 — intervention group
Group type: COMPARATOR
Intervention: Voice therapy
Number of subjects: 204
Study 10933407 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF)
Number of subjects: 45
Study 10933407 — intervention group
Group type: EXPERIMENTAL
Intervention: High-PUFA diet (HP)
Number of subjects: 45
Study 10933407 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA diet (HM)
Number of subjects: 45
Study 7868667 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination (IUI) after ovarian stimulation with HMG and HCG
Number of subjects: 76
Study 7868667 — intervention group
Group type: COMPARATOR
Intervention: Timed intercourse after ovarian stimulation with HMG and HCG
Number of subjects: 76
Study 3063046 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: Anesthesia induced with diazepam (94 micrograms x kg‐1), thiopentone (3 mg x kg‐1), and fentanyl (3 micrograms x kg‐1)
Number of subjects: 30
Study 3063046 — intervention group
Group type: COMPARATOR
Intervention: Group II: Anesthesia induced with fentanyl (30 micrograms x kg‐1)
Number of subjects: 30
Study 30925267 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine infusion
Number of subjects: 71
Study 30925267 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine infusion
Number of subjects: 71
Study 30925267 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion (normal saline)
Number of subjects: 71
Study 29122812 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg/d)
Number of subjects: 44
Study 29122812 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol succinate (100 mg/d)
Number of subjects: 44
Study 29122812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 29122812 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C coinfusion
Number of subjects: 44
Study 25300649 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D co-supplementation
Number of subjects: 104
Study 23388543 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine 2.0 to 2.5 mg/kg per day
Number of subjects: 23
Study 23388543 — intervention group
Group type: COMPARATOR
Intervention: Mesalamine 4 g/d
Number of subjects: 23
Study 21852221 — intervention group
Group type: EXPERIMENTAL
Intervention: RT(compFB)
Number of subjects: 31
Study 21852221 — intervention group
Group type: COMPARATOR
Intervention: RT(compNoFB)
Number of subjects: 31
Study 21852221 — intervention group
Group type: EXPERIMENTAL
Intervention: RT(clin)
Number of subjects: 31
Study 19083482 — intervention group
Group type: EXPERIMENTAL
Intervention: L-ornithine (2000 mg/d for 7 days and 6000 mg/d for 1 day as L-ornithine hydrochloride)
Number of subjects: 17
Study 19083482 — intervention group
Group type: EXPERIMENTAL
Intervention: L-ornithine
Number of subjects: 17
Study 19083482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 16868238 — intervention group
Group type: EXPERIMENTAL
Intervention: INFOFEED+NE
Number of subjects: 1337
Study 16868238 — intervention group
Group type: COMPARATOR
Intervention: INFOFEED
Number of subjects: 1337
Study 12757160 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin 200 mg
Number of subjects: 9
Study 12757160 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 8 mg
Number of subjects: 9
Study 12757160 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 9
Study 11144396 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir 14 mg/kg/day divided twice a day for 5 days
Number of subjects: 373
Study 11144396 — intervention group
Group type: COMPARATOR
Intervention: Cefprozil 30 mg/kg/day divided twice a day for 10 days
Number of subjects: 373
Study 11144396 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir
Number of subjects: 373
Study 11144396 — intervention group
Group type: COMPARATOR
Intervention: Cefprozil
Number of subjects: 373
Study 9058327 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% doxycycline hyclate (DH)
Number of subjects: 180
Study 9058327 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sanguinarium chloride (SC)
Number of subjects: 180
Study 9058327 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control (VC)
Number of subjects: 180
Study 30096092 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin (1100 mg/day)
Number of subjects: 50
Study 30096092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 25758623 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 140
Study 23659492 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner + implementation intentions
Number of subjects: 427
Study 23659492 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-only
Number of subjects: 427
Study 23659492 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions
Number of subjects: 427
Study 23659492 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 427
Study 21943810 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental RMTC (E-RMTC)
Number of subjects: 127
Study 21943810 — intervention group
Group type: COMPARATOR
Intervention: Control parole supervision and case management (PSCM)
Number of subjects: 127
Study 20082922 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 0
Study 20082922 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 to 40 mg daily
Number of subjects: 0
Study 16170525 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pain training by nursing staff
Number of subjects: 93
Study 16170525 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative pain training)
Number of subjects: 93
Study 16170525 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (increased levels of neuroticism)
Number of subjects: 93
Study 15278040 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical methods of hemostasis plus epinephrine injection
Number of subjects: 90
Study 15278040 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine injection alone
Number of subjects: 90
Study 11804427 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin (200 microg by nasal route twice a day)
Number of subjects: 238
Study 11804427 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide (0.5 mg by subcutaneous route once a day)
Number of subjects: 238
Study 9164885 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular rate control and anticoagulation
Number of subjects: 5300
Study 9164885 — intervention group
Group type: COMPARATOR
Intervention: Rhythm control and anticoagulation
Number of subjects: 5300
Study 9164885 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (ventricular rate control and rhythm control)
Number of subjects: 5300
Study 8203940 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement therapy
Number of subjects: 12
Study 2953500 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 100 micrograms X kg‐1 (n = 16)
Number of subjects: 33
Study 2953500 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 15 micrograms X kg‐1 (n = 17)
Number of subjects: 33
Study 31769226 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application (app) intervention for 4 months
Number of subjects: 82
Study 31769226 — intervention group
Group type: COMPARATOR
Intervention: Control group (no app intervention)
Number of subjects: 82
Study 31769226 — intervention group
Group type: EXPERIMENTAL
Intervention: App usage in weeks 1-4: 94%
Number of subjects: 82
Study 31769226 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean app use time per participant: Cancer Information: 6.9 minutes (SD: 18.9), Appointment Schedule: 5.1 minutes (SD: 9.6), Cancer Services: 1.5 minutes (SD: 6.8), Hospital Navigation: 1.4 minutes (SD: 2.8)
Number of subjects: 82
Study 29761242 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 66
Study 29761242 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 66
Study 28543914 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention premises audited by Environmental Health Practitioners with varying doses (informal advice, written advice, follow-up visits)
Number of subjects: 600
Study 28543914 — intervention group
Group type: COMPARATOR
Intervention: Control premises received usual practice
Number of subjects: 600
Study 26051483 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative bracing for three weeks after ACL reconstruction
Number of subjects: 60
Study 26051483 — intervention group
Group type: COMPARATOR
Intervention: No post-operative bracing for three weeks after ACL reconstruction
Number of subjects: 60
Study 26051483 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative bracing
Number of subjects: 60
Study 24175958 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index dietary intervention
Number of subjects: 800
Study 21940954 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid intima-media thickness
Number of subjects: 18155
Study 21940954 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid plaque presence
Number of subjects: 18155
Study 21940954 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocardiographic left ventricular hypertrophy
Number of subjects: 18155
Study 18245177 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine, 100 mg
Number of subjects: 23
Study 18245177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 16719601 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored nutrition education messages
Number of subjects: 24
Study 16719601 — intervention group
Group type: COMPARATOR
Intervention: Nontailored nutrition education messages
Number of subjects: 24
Study 15231442 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) treatment
Number of subjects: 38
Study 15231442 — intervention group
Group type: COMPARATOR
Intervention: Untreated MDD
Number of subjects: 38
Study 15231442 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 38
Study 15231442 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful treatment with antidepressants
Number of subjects: 38
Study 11196404 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum used regularly for 2 or 3 school years
Number of subjects: 0
Study 11196404 — intervention group
Group type: COMPARATOR
Intervention: Occlusal sealants applied
Number of subjects: 0
Study 9052367 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography in elite orienteers
Number of subjects: 143
Study 9052367 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography in controls
Number of subjects: 143
Study 8375791 — intervention group
Group type: EXPERIMENTAL
Intervention: Crataegus special extract WS 1442
Number of subjects: 30
Study 8375791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3098923 — intervention group
Group type: EXPERIMENTAL
Intervention: Progabide
Number of subjects: 64
Study 3098923 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 64
Study 3098923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 31451487 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-labeled PSMA-617
Number of subjects: 0
Study 31451487 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-targeted imaging
Number of subjects: 0
Study 28485095 — intervention group
Group type: EXPERIMENTAL
Intervention: myo-inositol
Number of subjects: 60
Study 28485095 — intervention group
Group type: COMPARATOR
Intervention: metformin
Number of subjects: 60
Study 25210833 — intervention group
Group type: COMPARATOR
Intervention: Conventional open plating (COP)
Number of subjects: 68
Study 25210833 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive plate osteosynthesis (MIPO)
Number of subjects: 68
Study 22932947 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gel capsule L-T4 taken with water (proper habit, PH)
Number of subjects: 8
Study 22932947 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gel capsule L-T4 taken with coffee ≤ 5 min later (improper habit, IH)
Number of subjects: 8
Study 22932947 — intervention group
Group type: COMPARATOR
Intervention: Soft gel capsule L-T4 taken with water (PH)
Number of subjects: 8
Study 22932947 — intervention group
Group type: COMPARATOR
Intervention: Soft gel capsule L-T4 taken with coffee (IH)
Number of subjects: 8
Study 20798662 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal of exercise for 1 week in highly active men (Study 1)
Number of subjects: 18
Study 20798662 — intervention group
Group type: COMPARATOR
Intervention: 30 min of daily walking at 60% VO(2max) for 1 week in sedentary men (Study 2)
Number of subjects: 18
Study 20798662 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRP in highly active men (Study 1)
Number of subjects: 18
Study 20798662 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRP in sedentary men (Study 2)
Number of subjects: 18
Study 19103494 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (n=27)
Number of subjects: 54
Study 19103494 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (n=27)
Number of subjects: 54
Study 19103494 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 54
Study 19103494 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 54
Study 17011155 — intervention group
Group type: EXPERIMENTAL
Intervention: Written information plus illustrations
Number of subjects: 318
Study 17011155 — intervention group
Group type: COMPARATOR
Intervention: Written information only
Number of subjects: 318
Study 15292698 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound (BR1, SonoVue, Bracco)
Number of subjects: 62
Study 11414003 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused attention induced by peripheral cues of varying sizes
Number of subjects: 0
Study 11414003 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral precue indicating target position
Number of subjects: 0
Study 11414003 — intervention group
Group type: COMPARATOR
Intervention: No specific control intervention mentioned
Number of subjects: 0
Study 9226291 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression rate of 5:1
Number of subjects: 1440
Study 9226291 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression rate of 6:1
Number of subjects: 1440
Study 9226291 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression rate of 11:1
Number of subjects: 1440
Study 9226291 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression rate of 43:1
Number of subjects: 1440
Study 8501502 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 600 mg/m2 + Carboplatin 300 mg/m2
Number of subjects: 224
Study 8501502 — intervention group
Group type: COMPARATOR
Intervention: Single-agent Carboplatin
Number of subjects: 224
Study 3114783 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 32 mg
Number of subjects: 20
Study 3114783 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 64 mg
Number of subjects: 20
Study 3114783 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 128 mg
Number of subjects: 20
Study 3114783 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 256 mg
Number of subjects: 20
Study 30717746 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral family‐based obesity intervention (LAUNCH)
Number of subjects: 0
Study 30717746 — intervention group
Group type: COMPARATOR
Intervention: Motivational interviewing (MI)
Number of subjects: 0
Study 30717746 — intervention group
Group type: COMPARATOR
Intervention: Standard care (STC)
Number of subjects: 0
Study 28298766 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher thoracic epidural analgesia (HTEA) with fentanyl and bupivacaine
Number of subjects: 60
Study 28298766 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl analgesia
Number of subjects: 60
Study 26431336 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal multiple micronutrient (MM) supplementation
Number of subjects: 396
Study 26431336 — intervention group
Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) supplementation
Number of subjects: 396
Study 23625090 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatrial (BiA) pacing
Number of subjects: 28
Study 23625090 — intervention group
Group type: COMPARATOR
Intervention: Right atrial appendage (RAA) pacing
Number of subjects: 28
Study 21543429 — intervention group
Group type: EXPERIMENTAL
Intervention: EST expression in subcutaneous adipose tissue
Number of subjects: 16
Study 20415678 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsphere adapalene gel, applied once daily in the evening for 12 weeks
Number of subjects: 175
Study 20415678 — intervention group
Group type: COMPARATOR
Intervention: Conventional adapalene gel, applied once daily in the evening for 12 weeks
Number of subjects: 175
Study 20415678 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsphere adapalene gel
Number of subjects: 175
Study 20415678 — intervention group
Group type: COMPARATOR
Intervention: Conventional adapalene gel
Number of subjects: 175
Study 20415678 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 175
Study 17760545 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) rinse
Number of subjects: 210
Study 17760545 — intervention group
Group type: COMPARATOR
Intervention: Control rinse
Number of subjects: 210
Study 15155217 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose voriconazole (3 mg/kg)
Number of subjects: 39
Study 15155217 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose voriconazole (4 mg/kg)
Number of subjects: 39
Study 15155217 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose voriconazole (6 mg/kg every 12 h on day 1, followed by 3 mg/kg every 12 h on day 2 to day 4 and 4 mg/kg every 12 h on day 4 to day 8)
Number of subjects: 39
Study 15155217 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole (any dosage)
Number of subjects: 39
Study 15155217 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole (4 mg/kg)
Number of subjects: 39
Study 12219055 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact training (jumping)
Number of subjects: 74
Study 12219055 — intervention group
Group type: COMPARATOR
Intervention: Control group (no high-impact training)
Number of subjects: 74
Study 9602227 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-stretch compression bandage
Number of subjects: 43
Study 9602227 — intervention group
Group type: COMPARATOR
Intervention: Short-stretch compression bandage
Number of subjects: 43
Study 7981559 — intervention group
Group type: EXPERIMENTAL
Intervention: maize-cowpea-palm oil diet (group MCP)
Number of subjects: 69
Study 7981559 — intervention group
Group type: COMPARATOR
Intervention: commercially produced lactose-free, soy protein isolate formula (group SF)
Number of subjects: 69
Study 2595636 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nebulised salbutamol
Number of subjects: 16
Study 2595636 — intervention group
Group type: COMPARATOR
Intervention: Matched saline placebo
Number of subjects: 16
Study 1146748 — intervention group
Group type: EXPERIMENTAL
Intervention: 34 g protein intake
Number of subjects: 15
Study 1146748 — intervention group
Group type: EXPERIMENTAL
Intervention: 57 g protein intake
Number of subjects: 15
Study 1146748 — intervention group
Group type: EXPERIMENTAL
Intervention: 88 g protein intake
Number of subjects: 15
Study 30782454 — intervention group
Group type: EXPERIMENTAL
Intervention: BS-SC group
Number of subjects: 96
Study 30782454 — intervention group
Group type: EXPERIMENTAL
Intervention: BS-U200
Number of subjects: 96
Study 30782454 — intervention group
Group type: EXPERIMENTAL
Intervention: ES-U200
Number of subjects: 96
Study 30782454 — intervention group
Group type: EXPERIMENTAL
Intervention: ES-SC
Number of subjects: 96
Study 28637740 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple iPads
Number of subjects: 40
Study 28637740 — intervention group
Group type: COMPARATOR
Intervention: Local standard low-vision aid care
Number of subjects: 40
Study 24902684 — intervention group
Group type: EXPERIMENTAL
Intervention: DD monitor (group B)
Number of subjects: 200
Study 24902684 — intervention group
Group type: COMPARATOR
Intervention: Regular monitor (group C)
Number of subjects: 200
Study 24902684 — intervention group
Group type: EXPERIMENTAL
Intervention: DD monitor (group D)
Number of subjects: 200
Study 24138011 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 316
Study 24138011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316